000 06112nam a2200769 a 4500
001 vtls000079400
003 MTX
006 m eo d
007 cr cn |||m|||a
008 160715s2013 nyua foab 001 0 eng d
020 _a9781606506028 (electronic bk.)
020 _z9781606506004 (print)
035 _a(CaPaEBR)10707485
035 _a(OCoLC)844954577
035 _a(CaBNvSL)swl00402449
039 9 _a201607151144
_bstaff
_y201605041227
_zadmin
040 _aCaBNVSL
_cCaBNVSL
_dCaBNVSL
050 4 _aQP801.P64
_bK263 2013
060 4 _aQT 36.5
_bK263b 2013
082 0 4 _a574.1924
_223
099 _aEbook
100 1 _aKapoor, Deepak N.
_9115934
245 1 0 _aBiocompatible nanomaterials for targeted and controlled delivery of biomacromolecules
_h[electronic resource] /
_cDeepak N. Kapoor and Sanju Dhawan.
260 _aNew York, N.Y. :
_bASME ;
_aNew York, N.Y. (222 East 46th Street, New York, NY 10017) :
_bMomentum Press,
_c2013.
300 _a1 electronic text (47 p.) :
_bill., digital file.
490 1 _aBiomedical and nanomedical technologies
504 _aIncludes bibliographical references (p. 38-47) and index.
505 0 _a1. Nanomaterials: a brief introduction --
505 8 _a2. Tissue and blood-material interactions -- 2.1 Tissue response -- 2.2 Blood response -- 2.3 Cellular response --
505 8 _a3. Biocompatibility --
505 8 _a4. Biodegradation --
505 8 _a5. Biocompatible and biodegradable nanomaterials -- 5.1 Organic nanomaterials -- 5.1.1 Natural and modified natural nanomaterials -- 5.1.2 Synthetic polymeric nanomaterials -- 5.2 Stealth nanomaterials -- 5.3 Inorganic nanomaterials -- 5.3.1 Carbon nanotubes (CNTs) -- 5.3.2 Quantum dots (QDs) -- 5.3.3 End-capped mesoporous silica nanoparticles -- 5.4 Metal nanoparticles -- 5.4.1 Gold nanoparticles (Au-Nps) -- 5.4.2 Silver nanoparticles -- 5.5 Magnetic nanoparticles -- 5.6 Nanocomposites, nanofibres and nanowires -- 5.7 Hybrid nanomaterials -- 5.8 Virus-like nanocarriers -- 5.9 Multifunctional nanoparticles --
505 8 _a6. Biomacromolecules -- 6.1 Cell penetrating peptides in biomacromolecular delivery -- 6.2 Targeted biomacromolecular delivery --
505 8 _a7. Challenges in biomacromolecular delivery --
505 8 _a8. Preparation techniques of biocompatible nanostructures -- 8.1 Top-down techniques -- 8.1.1 Dispersion of preformed polymers -- 8.1.2 Polymerization methods -- 8.1.3 Ionic gelation method for hydrophilic polymers -- 8.1.4 Hybrid assemblies -- 8.2 Bottom-up techniques -- 8.3 Scalable methods --
505 8 _a9. Characterization and evaluation -- 9.1 Drug-polymer compatibility -- 9.2 Particle size and shape -- 9.3 Zeta potential -- 9.4 Drug release evaluation -- 9.5 Conformational stability -- 9.6 Biocompatibility studies -- 9.7 Pre-clinical evaluation --
505 8 _a10. Regulatory perspectives --
505 8 _a11. Industrial viability --
505 8 _a12. Conclusions -- References.
506 _aRestricted to libraries which purchase an unrestricted PDF download via an IP.
520 3 _aNanomaterials are organic or inorganic entities employed for the construction of various nanostructured devices or systems with nanometric dimensions. These nanostructures may include nanoparticles, nanowires, nanotubes, nanocapsules, nanocomposites as well as nanoporous solids. Nanomaterials have gained immense recognition, particularly in biomacromolecular delivery, owing to their capability of controlling the release rate or targeting the therapeutic moieties at molecular, cellular and organ level. Additionally, the problems of conformational and degradation stability associated with biomacromolecules like peptides, proteins, and genes have been addressed successfully by employing these nanomaterials. The degradation products of these biocompatible nanomaterials are non-toxic, non-immunogenic and easily resorbable by the regular physiological processes. The present chapter endeavors to describe the role of nanomaterials in the design, fabrication and development of various nanostructured, biomacromolecular delivery systems and devices. The chapter presents a discussion on various physicochemical properties, preparation techniques and analytical tools for characterizing these systems. The mechanisms of cellular internalization of nanomaterial based targeted systems are also discussed. Taking lead from various successful case studies, the present chapter provides a bird's eye view on the current advances in the field of nanomaterial based biomacromolecular delivery. A brief overview pertaining to the regulatory requirements and commercialization of these systems is also included. Various challenges posed during the development, scale up and large-scale production is also discussed. In a nutshell, besides, providing the salient details about the formulation and applications of biocompatible nanomaterials, the chapter would act as a ready reference for drug delivery scientists, device fabrication engineers and medical researchers working in this area.
530 _aAlso available in print.
538 _aMode of access: World Wide Web.
538 _aSystem requirements: Adobe Acrobat reader.
588 _aTitle from PDF t.p. (viewed on May 29, 2013).
650 0 _aMacromolecules.
_9115935
650 0 _aNanostructured materials.
_9115936
650 0 _aDrug delivery systems.
_9115937
650 0 _aNanomedicine.
_9115923
650 2 _aNanostructures.
_9115938
650 2 _aDrug Delivery Systems.
_9115939
650 2 _aNanomedicine.
_9115923
653 _ananomaterials
653 _aengineering
653 _aorganic
653 _ainorganic entities
653 _abiomacromolecular delivery
653 _aregulatory requirements
653 _acommercialization
653 _abiocompatible
700 1 _aDhawan, Sanju.
_9115940
776 0 8 _iPrint version:
_z9781606506004
830 0 _aBiomedical & nanomedical technologies.
_9115941
856 4 0 _uhttp://portal.igpublish.com/iglibrary/search/MPB0000077.html
942 _c10
999 _c75949
_d75949